Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Quest Diagnostics Inc (DGX)  
$142.43 1.65 (1.17%) as of 4:30 Thu 5/16


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 134,770,000
Market Cap: 19.20(B)
Last Volume: 995,877 Avg Vol: 1,174,722
52 Week Range: $120.62 - $144.92
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:

    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  724
Guru Rank Value     : 1.3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 18,097 18,097 18,097 536,229
Total Sell Value $2,309,019 $2,309,019 $2,309,019 $75,325,755
Total People Sold 4 4 4 7
Total Sell Transactions 7 7 7 25
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 787
  Page 11 of 32  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Mendez Manuel O. SVP & Chief Commercial Officer   •       –      –    2021-02-17 4 A $0.00 $0 D/D 4,926 29,045     -
   Eglinton Manner Carrie SVP, Advanced Diagnostics   •       –      –    2021-02-17 4 A $0.00 $0 D/D 4,926 24,841     -
   Doherty Catherine T. SVP, Group Exec. Clin. Fran.   •       –      –    2021-02-17 4 A $0.00 $0 D/D 3,941 72,352     -
   Rusckowski Stephen H Chairman, CEO and President   •       •      –    2021-02-17 4 A $0.00 $0 D/D 21,551 259,298     -
   Davis J. E. EVP, General Diagnostics   •       –      –    2021-02-17 4 A $0.00 $0 D/D 5,665 43,751     -
   Guinan Mark Executive Vice President & CFO   •       –      –    2021-02-17 4 A $0.00 $0 D/D 5,665 79,244     -
   Deppe Michael J VP, Corp. Controller & CAO   •       –      –    2021-02-17 4 A $0.00 $0 D/D 715 25,863     -
   Prevoznik Michael E SVP & General Counsel   •       –      –    2021-02-17 4 A $0.00 $0 D/D 3,202 43,289     -
   Eglinton Manner Carrie SVP, Advanced Diagnostics   •       –      –    2021-01-04 4 D $119.00 $314,160 D/D (2,640) 19,896     -
   Guinan Mark Executive Vice President & CFO   •       –      –    2020-12-24 4 AS $120.06 $9,840,673 D/D (81,756) 73,579 15%     
   Guinan Mark Executive Vice President & CFO   •       –      –    2020-12-24 4 OE $66.51 $5,437,592 D/D 81,756 155,335     -
   Wilensky Gail R Director   –       •      –    2020-11-24 4 S $126.02 $770,120 D/D (6,111) 16,482 -1%     
   Wilensky Gail R Director   –       •      –    2020-11-24 4 OE $57.67 $352,391 D/D 6,111 22,593     -
   Stanzione Daniel Director   –       •      –    2020-11-23 4 AS $125.73 $1,417,459 D/D (11,223) 28,349 2%     
   Deppe Michael J VP, Corp. Controller & CAO   •       –      –    2020-10-21 4 AS $125.00 $1,306,250 D/D (10,450) 25,090 -5%     
   Deppe Michael J VP, Corp. Controller & CAO   •       –      –    2020-10-21 4 OE $56.82 $598,244 D/D 10,450 35,485     -
   Rusckowski Stephen H Chairman, CEO and President   •       •      –    2020-10-16 4 AS $120.00 $35,039,640 D/D (291,997) 237,747 -4%     
   Rusckowski Stephen H Chairman, CEO and President   •       •      –    2020-10-16 4 OE $66.51 $19,420,720 D/D 291,997 529,744     -
   Prevoznik Michael E SVP & General Counsel   •       –      –    2020-10-14 4 AS $119.00 $4,235,329 D/D (35,591) 40,087 -2%     
   Prevoznik Michael E SVP & General Counsel   •       –      –    2020-10-14 4 OE $52.17 $1,856,605 D/D 35,591 75,678     -
   Mendez Manuel O. SVP & Chief Commercial Officer   •       –      –    2020-10-06 4 D $114.01 $669,353 D/D (5,871) 23,982     -
   Doherty Catherine T. SVP, Group Exec. Clin. Fran.   •       –      –    2020-09-02 4 AS $110.57 $6,458,343 D/D (58,392) 68,411 13%     
   Doherty Catherine T. SVP, Group Exec. Clin. Fran.   •       –      –    2020-09-02 4 OE $66.51 $3,883,652 D/D 58,392 126,803     -
   Ring Timothy M Director   –       •      –    2020-06-08 4 AS $116.60 $1,367,718 D/D (11,730) 20,505 3%     
   Ring Timothy M Director   –       •      –    2020-06-08 4 OE $57.57 $686,209 D/D 11,730 32,235     -

  787 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 11 of 32
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed